COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 490: Articles 4891-4900  | Next

Mucociliary Clearance Augmenting Drugs Block SARS-Cov-2 Replication in Human Airway Epithelial Cells
Campos-Gomez, J., Fernandez Petty, C., Mazur, M., Tang, L., Solomon, G. M., Joseph, R., Li, Q., Peabody Lever, J. E., Hussain, S. S., Harrod, K. S., Onuoha, E., Kim, H., Rowe, S. M.
10.1101/2023.01.30.526308 — Posted: 2023-02-01
Structural prediction of chimeric immunogens to elicit targeted antibodies against betacoronaviruses
Simpson, J., Kasson, P. M.
10.1101/2023.01.31.526494 — Posted: 2023-02-01
Scalable neighbour search and alignment with uvaia
de Oliveira Martins, L., Mather, A. E., Page, A. J.
10.1101/2023.01.31.526458 — Posted: 2023-01-31
Current Status and Emerging Trends of COVID-19-related Studies in Seven ''Tropical Medicine''-entitled Journals
Zhang, X., Zhong, Z., Luo, P., Zhu, C., Huang, Y., Wu, C., Pan, X., Huang, Z.
10.1101/2023.01.30.23285173 — Posted: 2023-01-31
Coinfection with Strongyloides and SARS-CoV-2: protocol for a systematic review
Rosca, E. C., Heneghan, C., Spencer, E. A., Pluddemann, A., Maltoni, S., Gandini, S., ONAKPOYA, I., Evans, D., Conly, J. M., Jefferson, T.
10.1101/2023.01.30.23285219 — Posted: 2023-01-31
Single-cell multi-omic topic embedding reveals cell-type-specific and COVID-19 severity-related immune signatures
Zhou, M., Zhang, H., Bai, Z., Mann-Krzisnik, D., Wang, F., Li, Y.
10.1101/2023.01.31.526312 — Posted: 2023-01-31
A comprehensive survey of coronaviral main protease active site diversity in 3D: Identifying and analyzing drug discovery targets in search of broad specificity inhibitors for the next coronavirus pandemic
Lubin, J. H., Martinusen, S. G., Zardecki, C., Olivas, C., Bacorn, M., Balogun, M., Slaton, E. W., Wu, A. W., Sakeer, S., Hudson, B. P., Denard, C., Burley, S. K., Khare, S. D.
10.1101/2023.01.30.526101 — Posted: 2023-01-31
Fitness effects of mutations to SARS-CoV-2 proteins
Bloom, J. D., Neher, R. A.
10.1101/2023.01.30.526314 — Posted: 2023-01-31
Probable transmission of SARS-CoV-2 from an African lion to zoo employees
Siegrist, A. A., Richardson, K. L., Ghai, R. R., Pope, B., Yeadon, J., Culp, B., Barton Behravesh, C., Liu, L., Brown, J. A., Boyer, L.
10.1101/2023.01.29.23285159 — Posted: 2023-01-31
Systems biological assessment of the temporal dynamics of immunity to a viral infection in the first weeks and months of life
Wimmers, F., Burrell, A. R., Feng, Y., Zheng, H., Arunachalam, P. S., Hu, M., Spranger, S., Nyhoff, L., Joshi, D., Trisal, M., Awasthi, M., Bellusci, L., Ashraf, U., Kowli, S., Konvinse, K. C., Yang, E., Blanco, M., Pellegrini, K., Tharp, G., Hagan, T., Chinthrajah, R. S., Grifoni, A., Sette, A., Nadeau, K. C., Haslam, D. B., Bosinger, S. E., Wrammert, J., Maecker, H. T., Utz, P. J., Wang, T. T., Khurana, S., Khatri, P., Staat, M. A., Pulendran, B.
10.1101/2023.01.28.23285133 — Posted: 2023-01-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).